Orchestra BioMed Holdings, Inc.

US$5.68As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OBIOHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (10.39%)
Div yield —
ROE (397.30%)
Biotechnology
Beta (5Y) 0.55
PE TTM —
TSR TTM 45.64%
Mkt cap US$434.3M
ROIC (62.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.73
0.91%
(39.15%)
Hold 1|3|6|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.09
0.09
0.10
22.74%
23.04%
15.83%
34.18%
Revenue$M
42.13
44.02
45.20
46.08
3.85%
3.25%
8.45%
11.18%
Peers (US$434.3M)
Cap (US$)
PE
425.9M
18.15x
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
2.985
0.017
0.016
EBIT/Intx
1.230
0.145
0.143
Own earn%
(5.37)
0.38
1.08
Sh yield%
37.69
28.96
27.16
Owners
Insiders/Inst%
6.89
60.83
Short interest%
2.14
SBC / revenue%
3.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
39